HIV-1-INFECTION
Clinical trials for HIV-1-INFECTION explained in plain language.
Never miss a new study
Get alerted when new HIV-1-INFECTION trials appear
Sign up with your email to follow new studies for HIV-1-INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Weekly HIV pill study halted: what happened?
Disease control TerminatedThis study tested whether a new once-weekly oral pill (GS-1720 plus GS-4182) could control HIV-1 as well as the daily standard-of-care Biktarvy. It enrolled 73 adults newly diagnosed with HIV who had never taken HIV medication. The study was terminated early, so results are limit…
Matched conditions: HIV-1-INFECTION
Phase: PHASE2, PHASE3 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated May 17, 2026 00:58 UTC
-
Early HIV drug study halted after just 4 volunteers
Disease control TerminatedThis study tested a new experimental HIV medicine, GS-1219, in people living with HIV-1. The goal was to see if it was safe and could lower the amount of virus in the blood. Only 4 people took part before the study was stopped early. This was a very early (Phase 1) study, so it i…
Matched conditions: HIV-1-INFECTION
Phase: PHASE1 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
HIV drug study ends early: PRO 140 monotherapy tested for viral control
Disease control TerminatedThis study looked at whether HIV patients who already had the virus under control could keep it that way by taking only PRO 140 (a weekly shot) instead of their usual combination of HIV medicines. It included 56 adults who had completed a previous study. The trial was stopped ear…
Matched conditions: HIV-1-INFECTION
Phase: PHASE2, PHASE3 • Sponsor: CytoDyn, Inc. • Aim: Disease control
Last updated May 06, 2026 16:02 UTC
-
HIV and opioid treatment study halted: what we know
Knowledge-focused TerminatedThis study aimed to understand how different medications for opioid use disorder (like methadone or buprenorphine) impact the immune system in people with HIV. Researchers wanted to see if these drugs could reduce gut-related inflammation and improve immune recovery. The study wa…
Matched conditions: HIV-1-INFECTION
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated May 12, 2026 13:42 UTC